BDBM311089 N-ethyl-N-(2-(4-(2- hydroxypropan-2-yl)- 5-methyl-2H-1,2,3- triazol-2-ypethyl)-2- (trifluoromethoxy) benzamide::US10155750, Example 26

SMILES CCN(CCn1nc(C)c(n1)C(C)(C)O)C(=O)c1ccccc1OC(F)(F)F

InChI Key InChIKey=JGSAACWXHHJROW-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 311089   

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM311089(N-ethyl-N-(2-(4-(2- hydroxypropan-2-yl)- 5-methyl-...)
Affinity DataIC50:  1.00E+4nMAssay Description:The cells are seeded at 20,000 cells/well into Becton-Dickinson black 384-well clear bottom sterile plates coated with poly-D-lysine. All reagents we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM311089(N-ethyl-N-(2-(4-(2- hydroxypropan-2-yl)- 5-methyl-...)
Affinity DataIC50:  19nMAssay Description:The cells are seeded at 20,000 cells/well into Becton-Dickinson black 384-well clear bottom sterile plates coated with poly-D-lysine. All reagents we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent